In a significant milestone for the biopharmaceutical industry, AGC Biologics' Seattle site successfully underwent a multi-product inspection by the U.S. Food and Drug Administration (FDA) in March 2024. This comprehensive evaluation was aimed at supporting Biologics License Applications (BLA) for
The biopharmaceutical and life sciences industry is experiencing dynamic shifts, marked by strategic partnerships, innovative laboratory products, and enhanced service offerings. Companies are increasingly focusing on forming alliances, introducing state-of-the-art equipment, and improving their
In a recent strategic maneuver, Myriad Genetics, Inc., known for its pioneering work in genetic testing and precision medicine, officially announced the sale of its EndoPredict business unit to Eurobio Scientific. Based in Salt Lake City, Utah, Myriad's decision aligns with broader plans to
Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts The global biopharma market is on the cusp of remarkable transformations driven by automation, enabling more efficient production processes and improved product quality. This evolving sector is undergoing significant
The biomanufacturing industry is on the cusp of a transformative era, driven by technological innovations and strategic financial investments. A recent $7.5 million project agreement awarded to Capra Biosciences by the U.S. Department of Health and Human Services’ Administration for Strategic
Pharmaceutical manufacturing is evolving rapidly to keep pace with increasing global demand and stringent regulatory standards. A critical aspect of this evolution is the integration of automation systems to enhance data integrity. Automation ensures compliance with the ALCOA+
